Recalls / Firms / Harbin Jixianglong Biotech Co., Ltd.
Harbin Jixianglong Biotech Co., Ltd.
2 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2026-02-13 | Class II | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC | Ongoing |
| 2026-02-13 | Class II | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC | Ongoing |